AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 74(2), 2006, pp. 261-262
Copyright © 2006 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ARMSTRONG, G. L.
Right arrow Articles by McGARVEY, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ARMSTRONG, G. L.
Right arrow Articles by McGARVEY, S. T.
Related Collections
Right arrow Epidemiology
Right arrow Hepatitis

SHORT REPORT


HEPATITIS C VIRUS INFECTION IN SAMOA AND AMERICAN SAMOA

GREGORY L. ARMSTRONG*, IAN T. WILLIAMS, UTOOFILI ASOFA’AFETAI MAGA, SATUPAITEA VIALI, WENDI L. KUHNERT, AND STEPHEN T. McGARVEY
Division of Viral Hepatitis, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Department of Health, Government of American Samoa Pago Pago, American Samoa; Tupua Tamasese Meaole Hospital, Ministry of Health, Apia, Samoa; International Health Institute, Brown University, Providence, Rhode Island

 

ABSTRACT

Little is known about the prevalence of hepatitis C virus (HCV) in Pacific islands. In this study, serum specimens collected in 1985 and 2002 among the general populations of Samoa and American Samoa were tested for antibody to HCV by a third-generation enzyme immunoassay and a recombinant immunoblot assay. Of the 3,466 specimens tested, 8 (0.2%; 95% confidence interval = 0.07–0.4%) were positive for antibody to HCV. Prevalence did not vary by location or demographic characteristic. Thus, HCV is present in the Samoas but at a low prevalence.

Received July 30, 2005. Accepted for publication August 30, 2005.

Financial support: This project was supported by the U.S. Department of Interior for prevention of viral hepatitis in Pacific jurisdictions, and by National Institutes of Health grant R01 DK59642 to Stephen T. McGarvey.

* Address correspondence to Gregory L. Armstrong, Division of Viral Hepatitis, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Mailstop G-37, 1600 Clifton Road, NE, Atlanta, GA 30030. E-mail: garmstrong{at}cdc.gov

Authors’ addresses: Gregory L. Armstrong, Ian T. Williams, and Wendi L. Kuhnert, Division of Viral Hepatitis, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Mailstop G-37, 1600 Clifton Road, NE, Atlanta, GA 30330, Telephone: 404-371-5345, Fax: 404-371-5221, E-mails: garmstrong{at}cdc.gov, iwillliams{at}cdc.gov, and wkuhnert{at}cdc.gov. Utoofili Asofa’afetai Maga, Department of Health, Government of American Samoa, Pago Pago, American Samoa, E-mail: magaaso{at}hotmail.com. Satupaitea Viali, Tupua Tamasese Meaole Hospital, Ministry of Health, Apia, Samoa, E-mail: sviali{at}yahoo.com. Stephen T. McGarvey, International Health Institute, Brown University, Box G-B495, Providence, RI 02912, E-mail: stephen_mcgarvey{at}brown.edu.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society of Tropical Medicine and Hygiene.